PRENW

About Prenetics Global Limited

Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.

CEO: Sheng Wu Yeung
IPO Date: Jul 16, 2021

Market Data

Open: $0.0131
High: $0.016
Low: $0.0131
Volume: 201
Avg Volume: 34.3K
52W High: $0.022
52W Low: $0.016

Valuation

Market Cap: $241k
Enterprise Value: $293M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-22M
Revenue: $92M
Net Income: $-38M
Cash: $32M
Debt: $2.2M

Events

EarningsSep 11

EPS est. -0.702